PhRMA launches a seven-figure ad blitz to push for a crackdown on pharmaceutical middlemen, focusing on saving benefits for patients. The push is part of a final sprint to pass PBM reforms in the lame-duck session. Lobbying efforts target lawmakers to act before the new Congress.